PODCAST-19: FiveThirtyEight on the Novel Coronavirus
A podcast by FiveThirtyEight, Anna Rothschild
46 Episodio
-
How To Vote Safely In A Pandemic
Pubblicato: 29/10/2020 -
Would Biden’s COVID-19 Plan Be Able To Control The Pandemic?
Pubblicato: 16/10/2020 -
The President Took A Rare Combo Of COVID-19 Drugs. Will It Help?
Pubblicato: 07/10/2020 -
The Significance Of Trump Testing Positive For COVID-19
Pubblicato: 02/10/2020 -
The New College Experience
Pubblicato: 26/09/2020 -
Can We Trust A Vaccine That Gets Approved?
Pubblicato: 19/09/2020 -
Why A Vaccine Trial Would Press Pause
Pubblicato: 12/09/2020 -
The U.S. Wants Out Of A Global Effort To Stop A Global Pandemic
Pubblicato: 04/09/2020 -
What's It Going To Take For Us To Become Immune?
Pubblicato: 28/08/2020 -
Russia Approved A COVID Vaccine. Will It Be Available In America?
Pubblicato: 14/08/2020 -
PODCAST-19 Has The Week Off!
Pubblicato: 07/08/2020 -
Lab-Grown Antibodies Might Protect Essential Workers
Pubblicato: 31/07/2020 -
It's Harder to Get A COVID Test If You're Black Or Hispanic
Pubblicato: 24/07/2020 -
When Does A Pandemic Start To Erode Civil Liberties?
Pubblicato: 17/07/2020 -
Dr. Anthony Fauci Talks With PODCAST-19
Pubblicato: 09/07/2020 -
How To Convince People To Stop A Pandemic
Pubblicato: 03/07/2020 -
Do Masks Actually Work?
Pubblicato: 26/06/2020 -
Who Will Be First To Get A COVID Vaccine?
Pubblicato: 19/06/2020 -
The Case Of The Bogus Hydroxycholoroquine Study
Pubblicato: 12/06/2020 -
What It's Like To Be A Black Doctor And Nurse Right Now
Pubblicato: 05/06/2020
FiveThirtyEight's COVID-19 podcast is laser-focused on evidence. What do we know about the novel coronavirus, and what do we know we don't know? COVID-19 has pushed Americans into more uncertain territory than most have ever known. Our podcast helps listeners understand what they can be certain about, and what is still unknown. We investigate coronavirus mysteries, debate when it's safe to reopen the economy and keep track of the latest scientific developments on vaccines and treatments. We do it all with FiveThirtyEight's trademark blend of transparency and rigor.
